Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02860286
Title Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Epizyme, Inc.
Age Groups: senior | adult
Covered Countries USA | FRA

No variant requirements are available.